Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide Effects on Muscle and Performance in Athletes
NCT07874932Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised trial in obesity comparing Semaglutide with Placebo (2 arms). Primary endpoint: Change in total lean mass at 16 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07874932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07874932.